Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food

  title={Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food},
  author={G. Chittick and C. Gillotin and J. A. McDowell and Y. Lou and K. D. Edwards and W. Prince and D. Stein},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  • G. Chittick, C. Gillotin, +4 authors D. Stein
  • Published 1999
  • Medicine
  • Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  • Study Objectives. Study A: to determine the absolute bioavailability of a single 300‐mg abacavir hemisulfate tablet. Study B: to determine the bioequivalence of two oral abacavir formulations (300‐mg hemisulfate tablet, 100‐mg succinate caplet), the effect of food on the bioavailability of the 300‐mg hemisulfate tablet, and the bioavailability of the hemisulfate tablet relative to the hemisulfate solution. 
    52 Citations

    Paper Mentions

    The way abacavir (ABC) behaves in the body differs between children and adults, but little is known about ABC in adolescents. It is unclear if adult doses of ABC are appropriate for… Expand
    ConditionsHIV Infections
    Bioequivalence of a Dolutegravir, Abacavir, and Lamivudine Fixed-Dose Combination Tablet and the Effect of Food
    • 29
    • PDF
    Abacavir/Lamivudine/Zidovudme As a Combined Formulation Tablet: Bioequivalence Compared with Each Component Administered Concurrently and the Effect of Food on Absorption
    • 34
    Effect of Food on the Oral Bioavailability of Didanosine from Encapsulated Enteric‐Coated Beads
    • 31
    A Review of the Pharmacokinetics of Abacavir
    • 98
    The role of formulation on the pharmacokinetics of antiretroviral drugs
    • 15


    Food‐induced reduction in bioavailability of didanosine
    • 55
    Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.
    • 27
    • PDF
    Pharmacokinetics and bioavailability of zidovudine in humans.
    • 121
    Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related Disorders
    • 94